AI

This comes as injewelme prepares to deploy its proprietary technology following trials with SingHealth Polyclinics.

Joyful Health secured $17 million for AI revenue cycle management offering, and Osteoboost Health closed an $8 million round for its wearable osteopenia device.

HIMSS' public policy principles suggest AI guardrails to keep AI safe and trustworthy and recommend that they apply across the U.S. to prevent complications for developers, says HIMSS' Jonathan French.

Also, Neurophet has raised over $20 million for the development and global expansion of its AI-based brain imaging analysis software suite.

Sophia Brown, RN, Strategic Informatics Solutions' founder and CEO, recommends that health systems allow clinicians to test new AI tools before implementation to ensure they work well and are useful.

Dr. Matt Sakumoto, Nabla's chief clinical product officer, says he wants the next wave of AI tools to empower every member of a clinical team to collect patients' stories and follow them along their care journey.

Despite progress in using advanced analytics, Jill Seys, senior director for North America analytics at HIMSS, says that many healthcare organizations are still challenged with tailoring communications for patients.

AI can streamline workflows across health systems, but Greg O'Neill, ChristianaCare's director of patient education, says the technology misses its purpose if the information it provides to patients and families isn't useful.

The platform offers AI models and agents that help scientists design, test and iterate experiments to identify and analyze potential antibody therapies.

According to HIMSS' Tom Leary and Luis Belen, CEO of NHIT, NHIT INSPIRED connects college students with HIMSS mentors and industry partners. The program has shown early success in helping students find industry jobs.